Vinay Prasad is back at the FDA, and in a position in which grappling with nuance — not always his strong suit — will be the ...

Specifically, the latest guidelines say that researchers should not use any stem cell-based embryo models to try to start a ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

Telehealth is increasingly an option for pregnant people seeking abortions in the United States — even those who live in ...

A small study finds that an off-the-shelf vaccine candidate by Elicio Therapeutics boosted immune response in pancreatic ...

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Plus more pharma news from the Pharmalittle newsletter.

Today, we discuss lots of government maneuvering that impacts biopharma — starting, of course, with the FDA reinstating Vinay ...

The most cumbersome administrative obstacles that new primary care practices face have little to do with federal regulation.

Because of the unglamorous, underfunded, lifesaving work of the World Health Organization, the National Institutes of Health, ...

In every way, a study published this January in a major medical journal was a win for UnitedHealth Group. It showed that ...

He could appeal the decision to the director of the NIH, Dr. Jay Bhattacharya. It was a name Garber knew exceptionally well. For more than three decades, Garber had nurtured Bhattacharya’s career, ...